Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS.
Kereiakes DJ, Tcheng J, Fry ET, Bhatt DL, Bosker G, Diez JG, Ferguson JJ 3rd, Levine GN, Schaer GL, Zidar J; CATH Clinical Consensus Panel. Kereiakes DJ, et al. Among authors: zidar j. J Invasive Cardiol. 2003 Sep;15(9):536-53. J Invasive Cardiol. 2003. PMID: 12947218 Review. No abstract available.
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.
Kereiakes DJ, Grines C, Fry E, Esente P, Hoppensteadt D, Midei M, Barr L, Matthai W, Todd M, Broderick T, Rubinstein R, Fareed J, Santoian E, Neiderman A, Brodie B, Zidar J, Ferguson JJ, Cohen M; NICE 1 and NICE 4 Investigators. National Investigators Collaborating on Enoxaparin. Kereiakes DJ, et al. Among authors: zidar j. J Invasive Cardiol. 2001 Apr;13(4):272-8. J Invasive Cardiol. 2001. PMID: 11287711 Clinical Trial.
Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial.
Berger PB, Mahaffey KW, Meier SJ, Buller CE, Batchelor W, Fry ET, Zidar JP; ATLAST Investigators. Berger PB, et al. Among authors: zidar jp. Am Heart J. 2002 May;143(5):841-6. doi: 10.1067/mhj.2002.121929. Am Heart J. 2002. PMID: 12040346 Clinical Trial.
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
Fitzgerald PJ, Oshima A, Hayase M, Metz JA, Bailey SR, Baim DS, Cleman MW, Deutsch E, Diver DJ, Leon MB, Moses JW, Oesterle SN, Overlie PA, Pepine CJ, Safian RD, Shani J, Simonton CA, Smalling RW, Teirstein PS, Zidar JP, Yeung AC, Kuntz RE, Yock PG. Fitzgerald PJ, et al. Among authors: zidar jp. Circulation. 2000 Aug 1;102(5):523-30. doi: 10.1161/01.cir.102.5.523. Circulation. 2000. PMID: 10920064 Clinical Trial.
152 results